nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—RYR2—seminal vesicle—testicular cancer	0.0493	0.179	CbGeAlD
Hydralazine—AOC3—seminal vesicle—testicular cancer	0.0297	0.108	CbGeAlD
Hydralazine—RYR2—female gonad—testicular cancer	0.029	0.105	CbGeAlD
Hydralazine—RYR2—testis—testicular cancer	0.0257	0.0933	CbGeAlD
Hydralazine—P4HA1—seminal vesicle—testicular cancer	0.0237	0.0862	CbGeAlD
Hydralazine—AOC3—gonad—testicular cancer	0.0215	0.0779	CbGeAlD
Hydralazine—AOC3—female gonad—testicular cancer	0.0174	0.0633	CbGeAlD
Hydralazine—P4HA1—gonad—testicular cancer	0.0172	0.0623	CbGeAlD
Hydralazine—AOC3—testis—testicular cancer	0.0155	0.0562	CbGeAlD
Hydralazine—P4HA1—female gonad—testicular cancer	0.0139	0.0506	CbGeAlD
Hydralazine—P4HA1—testis—testicular cancer	0.0124	0.0449	CbGeAlD
Hydralazine—AOC3—lymph node—testicular cancer	0.0112	0.0407	CbGeAlD
Hydralazine—P4HA1—lymph node—testicular cancer	0.00896	0.0325	CbGeAlD
Hydralazine—Vascular purpura—Epirubicin—testicular cancer	0.00158	0.00219	CcSEcCtD
Hydralazine—Oedema—Ifosfamide—testicular cancer	0.00157	0.00217	CcSEcCtD
Hydralazine—Chills—Etoposide—testicular cancer	0.00157	0.00217	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00156	0.00216	CcSEcCtD
Hydralazine—Cardiac failure congestive—Epirubicin—testicular cancer	0.00156	0.00216	CcSEcCtD
Hydralazine—Tremor—Cisplatin—testicular cancer	0.00156	0.00215	CcSEcCtD
Hydralazine—Ill-defined disorder—Cisplatin—testicular cancer	0.00154	0.00213	CcSEcCtD
Hydralazine—Thrombocytopenia—Ifosfamide—testicular cancer	0.00154	0.00213	CcSEcCtD
Hydralazine—Lymphadenopathy—Doxorubicin—testicular cancer	0.00154	0.00212	CcSEcCtD
Hydralazine—Anaemia—Cisplatin—testicular cancer	0.00154	0.00212	CcSEcCtD
Hydralazine—Renal failure acute—Epirubicin—testicular cancer	0.00154	0.00212	CcSEcCtD
Hydralazine—Feeling abnormal—Bleomycin—testicular cancer	0.00152	0.00209	CcSEcCtD
Hydralazine—Vomiting—Chlorambucil—testicular cancer	0.00151	0.00209	CcSEcCtD
Hydralazine—Hepatic function abnormal—Doxorubicin—testicular cancer	0.0015	0.00207	CcSEcCtD
Hydralazine—Anorexia—Ifosfamide—testicular cancer	0.0015	0.00207	CcSEcCtD
Hydralazine—Malaise—Cisplatin—testicular cancer	0.0015	0.00207	CcSEcCtD
Hydralazine—Decreased appetite—Dactinomycin—testicular cancer	0.00149	0.00206	CcSEcCtD
Hydralazine—Diarrhoea—Vinblastine—testicular cancer	0.00149	0.00206	CcSEcCtD
Hydralazine—Leukopenia—Cisplatin—testicular cancer	0.00149	0.00205	CcSEcCtD
Hydralazine—Purpura—Epirubicin—testicular cancer	0.00147	0.00203	CcSEcCtD
Hydralazine—Hypotension—Ifosfamide—testicular cancer	0.00147	0.00203	CcSEcCtD
Hydralazine—Vascular purpura—Doxorubicin—testicular cancer	0.00147	0.00202	CcSEcCtD
Hydralazine—Muscle spasms—Etoposide—testicular cancer	0.00146	0.00202	CcSEcCtD
Hydralazine—Urticaria—Bleomycin—testicular cancer	0.00146	0.00202	CcSEcCtD
Hydralazine—Body temperature increased—Bleomycin—testicular cancer	0.00146	0.00201	CcSEcCtD
Hydralazine—Cardiac failure—Epirubicin—testicular cancer	0.00145	0.002	CcSEcCtD
Hydralazine—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00145	0.002	CcSEcCtD
Hydralazine—Dizziness—Vinblastine—testicular cancer	0.00144	0.00199	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00143	0.00198	CcSEcCtD
Hydralazine—Renal failure acute—Doxorubicin—testicular cancer	0.00142	0.00196	CcSEcCtD
Hydralazine—Myalgia—Cisplatin—testicular cancer	0.00142	0.00195	CcSEcCtD
Hydralazine—Feeling abnormal—Dactinomycin—testicular cancer	0.00141	0.00195	CcSEcCtD
Hydralazine—Nausea—Chlorambucil—testicular cancer	0.00141	0.00195	CcSEcCtD
Hydralazine—Paraesthesia—Ifosfamide—testicular cancer	0.00141	0.00195	CcSEcCtD
Hydralazine—Ill-defined disorder—Etoposide—testicular cancer	0.00141	0.00195	CcSEcCtD
Hydralazine—Anxiety—Cisplatin—testicular cancer	0.00141	0.00195	CcSEcCtD
Hydralazine—Anaemia—Etoposide—testicular cancer	0.00141	0.00194	CcSEcCtD
Hydralazine—Dyspnoea—Ifosfamide—testicular cancer	0.0014	0.00194	CcSEcCtD
Hydralazine—Discomfort—Cisplatin—testicular cancer	0.0014	0.00193	CcSEcCtD
Hydralazine—Vomiting—Vinblastine—testicular cancer	0.00139	0.00191	CcSEcCtD
Hydralazine—Malaise—Etoposide—testicular cancer	0.00137	0.00189	CcSEcCtD
Hydralazine—Decreased appetite—Ifosfamide—testicular cancer	0.00137	0.00189	CcSEcCtD
Hydralazine—Headache—Vinblastine—testicular cancer	0.00137	0.00188	CcSEcCtD
Hydralazine—Leukopenia—Etoposide—testicular cancer	0.00136	0.00188	CcSEcCtD
Hydralazine—Purpura—Doxorubicin—testicular cancer	0.00136	0.00188	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00136	0.00187	CcSEcCtD
Hydralazine—Body temperature increased—Dactinomycin—testicular cancer	0.00136	0.00187	CcSEcCtD
Hydralazine—Oedema—Cisplatin—testicular cancer	0.00136	0.00187	CcSEcCtD
Hydralazine—Hypersensitivity—Bleomycin—testicular cancer	0.00136	0.00187	CcSEcCtD
Hydralazine—Constipation—Ifosfamide—testicular cancer	0.00135	0.00186	CcSEcCtD
Hydralazine—Cardiac failure—Doxorubicin—testicular cancer	0.00134	0.00185	CcSEcCtD
Hydralazine—Thrombocytopenia—Cisplatin—testicular cancer	0.00133	0.00183	CcSEcCtD
Hydralazine—Tachycardia—Cisplatin—testicular cancer	0.00132	0.00183	CcSEcCtD
Hydralazine—Pruritus—Bleomycin—testicular cancer	0.0013	0.0018	CcSEcCtD
Hydralazine—Feeling abnormal—Ifosfamide—testicular cancer	0.0013	0.00179	CcSEcCtD
Hydralazine—Eosinophilia—Methotrexate—testicular cancer	0.0013	0.00179	CcSEcCtD
Hydralazine—Nausea—Vinblastine—testicular cancer	0.00129	0.00179	CcSEcCtD
Hydralazine—Anorexia—Cisplatin—testicular cancer	0.00129	0.00178	CcSEcCtD
Hydralazine—Discomfort—Etoposide—testicular cancer	0.00128	0.00177	CcSEcCtD
Hydralazine—Hypotension—Cisplatin—testicular cancer	0.00127	0.00175	CcSEcCtD
Hydralazine—Hypersensitivity—Dactinomycin—testicular cancer	0.00127	0.00175	CcSEcCtD
Hydralazine—Urticaria—Ifosfamide—testicular cancer	0.00125	0.00172	CcSEcCtD
Hydralazine—Body temperature increased—Ifosfamide—testicular cancer	0.00124	0.00172	CcSEcCtD
Hydralazine—Pancytopenia—Methotrexate—testicular cancer	0.00124	0.00172	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00124	0.00171	CcSEcCtD
Hydralazine—Dysuria—Methotrexate—testicular cancer	0.00122	0.00169	CcSEcCtD
Hydralazine—Neutropenia—Methotrexate—testicular cancer	0.00122	0.00169	CcSEcCtD
Hydralazine—Paraesthesia—Cisplatin—testicular cancer	0.00122	0.00168	CcSEcCtD
Hydralazine—Thrombocytopenia—Etoposide—testicular cancer	0.00122	0.00168	CcSEcCtD
Hydralazine—Tachycardia—Etoposide—testicular cancer	0.00121	0.00167	CcSEcCtD
Hydralazine—Eosinophilia—Epirubicin—testicular cancer	0.00121	0.00167	CcSEcCtD
Hydralazine—Dyspnoea—Cisplatin—testicular cancer	0.00121	0.00167	CcSEcCtD
Hydralazine—Angina pectoris—Epirubicin—testicular cancer	0.00119	0.00165	CcSEcCtD
Hydralazine—Anorexia—Etoposide—testicular cancer	0.00118	0.00163	CcSEcCtD
Hydralazine—Decreased appetite—Cisplatin—testicular cancer	0.00118	0.00163	CcSEcCtD
Hydralazine—Diarrhoea—Dactinomycin—testicular cancer	0.00117	0.00162	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00117	0.00162	CcSEcCtD
Hydralazine—Vomiting—Bleomycin—testicular cancer	0.00117	0.00162	CcSEcCtD
Hydralazine—Depression—Methotrexate—testicular cancer	0.00116	0.00161	CcSEcCtD
Hydralazine—Pancytopenia—Epirubicin—testicular cancer	0.00116	0.00161	CcSEcCtD
Hydralazine—Hypotension—Etoposide—testicular cancer	0.00116	0.0016	CcSEcCtD
Hydralazine—Rash—Bleomycin—testicular cancer	0.00116	0.0016	CcSEcCtD
Hydralazine—Dermatitis—Bleomycin—testicular cancer	0.00116	0.0016	CcSEcCtD
Hydralazine—Hypersensitivity—Ifosfamide—testicular cancer	0.00116	0.0016	CcSEcCtD
Hydralazine—Neutropenia—Epirubicin—testicular cancer	0.00115	0.00158	CcSEcCtD
Hydralazine—Dysuria—Epirubicin—testicular cancer	0.00115	0.00158	CcSEcCtD
Hydralazine—Conjunctivitis—Methotrexate—testicular cancer	0.00113	0.00157	CcSEcCtD
Hydralazine—Eosinophilia—Doxorubicin—testicular cancer	0.00112	0.00155	CcSEcCtD
Hydralazine—Feeling abnormal—Cisplatin—testicular cancer	0.00112	0.00154	CcSEcCtD
Hydralazine—Paraesthesia—Etoposide—testicular cancer	0.00112	0.00154	CcSEcCtD
Hydralazine—Pruritus—Ifosfamide—testicular cancer	0.00111	0.00154	CcSEcCtD
Hydralazine—Haematuria—Methotrexate—testicular cancer	0.00111	0.00154	CcSEcCtD
Hydralazine—Weight decreased—Epirubicin—testicular cancer	0.00111	0.00153	CcSEcCtD
Hydralazine—Dyspnoea—Etoposide—testicular cancer	0.00111	0.00153	CcSEcCtD
Hydralazine—Angina pectoris—Doxorubicin—testicular cancer	0.0011	0.00152	CcSEcCtD
Hydralazine—Nausea—Bleomycin—testicular cancer	0.00109	0.00151	CcSEcCtD
Hydralazine—Vomiting—Dactinomycin—testicular cancer	0.00109	0.00151	CcSEcCtD
Hydralazine—Agranulocytosis—Methotrexate—testicular cancer	0.00109	0.0015	CcSEcCtD
Hydralazine—Rash—Dactinomycin—testicular cancer	0.00108	0.00149	CcSEcCtD
Hydralazine—Decreased appetite—Etoposide—testicular cancer	0.00108	0.00149	CcSEcCtD
Hydralazine—Diarrhoea—Ifosfamide—testicular cancer	0.00108	0.00149	CcSEcCtD
Hydralazine—Pancytopenia—Doxorubicin—testicular cancer	0.00108	0.00149	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00107	0.00148	CcSEcCtD
Hydralazine—Body temperature increased—Cisplatin—testicular cancer	0.00107	0.00148	CcSEcCtD
Hydralazine—Neuropathy peripheral—Epirubicin—testicular cancer	0.00107	0.00148	CcSEcCtD
Hydralazine—Jaundice—Epirubicin—testicular cancer	0.00106	0.00147	CcSEcCtD
Hydralazine—Constipation—Etoposide—testicular cancer	0.00106	0.00147	CcSEcCtD
Hydralazine—Conjunctivitis—Epirubicin—testicular cancer	0.00106	0.00147	CcSEcCtD
Hydralazine—Dysuria—Doxorubicin—testicular cancer	0.00106	0.00146	CcSEcCtD
Hydralazine—Neutropenia—Doxorubicin—testicular cancer	0.00106	0.00146	CcSEcCtD
Hydralazine—Hepatitis—Methotrexate—testicular cancer	0.00105	0.00145	CcSEcCtD
Hydralazine—Haematuria—Epirubicin—testicular cancer	0.00104	0.00144	CcSEcCtD
Hydralazine—Dizziness—Ifosfamide—testicular cancer	0.00104	0.00144	CcSEcCtD
Hydralazine—Weight decreased—Doxorubicin—testicular cancer	0.00103	0.00142	CcSEcCtD
Hydralazine—Feeling abnormal—Etoposide—testicular cancer	0.00102	0.00141	CcSEcCtD
Hydralazine—Nausea—Dactinomycin—testicular cancer	0.00102	0.00141	CcSEcCtD
Hydralazine—Agranulocytosis—Epirubicin—testicular cancer	0.00102	0.00141	CcSEcCtD
Hydralazine—Vomiting—Ifosfamide—testicular cancer	0.001	0.00138	CcSEcCtD
Hydralazine—Hypersensitivity—Cisplatin—testicular cancer	0.000999	0.00138	CcSEcCtD
Hydralazine—Rash—Ifosfamide—testicular cancer	0.000992	0.00137	CcSEcCtD
Hydralazine—Dermatitis—Ifosfamide—testicular cancer	0.000991	0.00137	CcSEcCtD
Hydralazine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000991	0.00137	CcSEcCtD
Hydralazine—Urticaria—Etoposide—testicular cancer	0.000987	0.00136	CcSEcCtD
Hydralazine—Jaundice—Doxorubicin—testicular cancer	0.000985	0.00136	CcSEcCtD
Hydralazine—Body temperature increased—Etoposide—testicular cancer	0.000982	0.00136	CcSEcCtD
Hydralazine—Conjunctivitis—Doxorubicin—testicular cancer	0.000982	0.00136	CcSEcCtD
Hydralazine—Hepatitis—Epirubicin—testicular cancer	0.000981	0.00135	CcSEcCtD
Hydralazine—Hypoaesthesia—Epirubicin—testicular cancer	0.000976	0.00135	CcSEcCtD
Hydralazine—Haematuria—Doxorubicin—testicular cancer	0.000964	0.00133	CcSEcCtD
Hydralazine—Agranulocytosis—Doxorubicin—testicular cancer	0.000943	0.0013	CcSEcCtD
Hydralazine—Chills—Methotrexate—testicular cancer	0.00094	0.0013	CcSEcCtD
Hydralazine—Nausea—Ifosfamide—testicular cancer	0.000935	0.00129	CcSEcCtD
Hydralazine—Diarrhoea—Cisplatin—testicular cancer	0.000928	0.00128	CcSEcCtD
Hydralazine—Hypersensitivity—Etoposide—testicular cancer	0.000916	0.00126	CcSEcCtD
Hydralazine—Flushing—Epirubicin—testicular cancer	0.00091	0.00126	CcSEcCtD
Hydralazine—Hepatitis—Doxorubicin—testicular cancer	0.000907	0.00125	CcSEcCtD
Hydralazine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000903	0.00125	CcSEcCtD
Hydralazine—Chills—Epirubicin—testicular cancer	0.00088	0.00121	CcSEcCtD
Hydralazine—Pruritus—Etoposide—testicular cancer	0.000879	0.00121	CcSEcCtD
Hydralazine—Vomiting—Cisplatin—testicular cancer	0.000862	0.00119	CcSEcCtD
Hydralazine—Rash—Cisplatin—testicular cancer	0.000855	0.00118	CcSEcCtD
Hydralazine—Dermatitis—Cisplatin—testicular cancer	0.000855	0.00118	CcSEcCtD
Hydralazine—Diarrhoea—Etoposide—testicular cancer	0.00085	0.00117	CcSEcCtD
Hydralazine—Ill-defined disorder—Methotrexate—testicular cancer	0.000846	0.00117	CcSEcCtD
Hydralazine—Anaemia—Methotrexate—testicular cancer	0.000843	0.00116	CcSEcCtD
Hydralazine—Flushing—Doxorubicin—testicular cancer	0.000842	0.00116	CcSEcCtD
Hydralazine—Malaise—Methotrexate—testicular cancer	0.000823	0.00114	CcSEcCtD
Hydralazine—Dizziness—Etoposide—testicular cancer	0.000822	0.00113	CcSEcCtD
Hydralazine—Muscle spasms—Epirubicin—testicular cancer	0.000821	0.00113	CcSEcCtD
Hydralazine—Leukopenia—Methotrexate—testicular cancer	0.000816	0.00113	CcSEcCtD
Hydralazine—Chills—Doxorubicin—testicular cancer	0.000814	0.00112	CcSEcCtD
Hydralazine—Nausea—Cisplatin—testicular cancer	0.000806	0.00111	CcSEcCtD
Hydralazine—Ill-defined disorder—Epirubicin—testicular cancer	0.000792	0.00109	CcSEcCtD
Hydralazine—Vomiting—Etoposide—testicular cancer	0.00079	0.00109	CcSEcCtD
Hydralazine—Anaemia—Epirubicin—testicular cancer	0.000789	0.00109	CcSEcCtD
Hydralazine—Agitation—Epirubicin—testicular cancer	0.000784	0.00108	CcSEcCtD
Hydralazine—Rash—Etoposide—testicular cancer	0.000784	0.00108	CcSEcCtD
Hydralazine—Dermatitis—Etoposide—testicular cancer	0.000783	0.00108	CcSEcCtD
Hydralazine—Headache—Etoposide—testicular cancer	0.000779	0.00107	CcSEcCtD
Hydralazine—Myalgia—Methotrexate—testicular cancer	0.000777	0.00107	CcSEcCtD
Hydralazine—Arthralgia—Methotrexate—testicular cancer	0.000777	0.00107	CcSEcCtD
Hydralazine—Malaise—Epirubicin—testicular cancer	0.00077	0.00106	CcSEcCtD
Hydralazine—Discomfort—Methotrexate—testicular cancer	0.000767	0.00106	CcSEcCtD
Hydralazine—Leukopenia—Epirubicin—testicular cancer	0.000764	0.00105	CcSEcCtD
Hydralazine—Muscle spasms—Doxorubicin—testicular cancer	0.000759	0.00105	CcSEcCtD
Hydralazine—Palpitations—Epirubicin—testicular cancer	0.000754	0.00104	CcSEcCtD
Hydralazine—Nausea—Etoposide—testicular cancer	0.000738	0.00102	CcSEcCtD
Hydralazine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000733	0.00101	CcSEcCtD
Hydralazine—Anaemia—Doxorubicin—testicular cancer	0.00073	0.00101	CcSEcCtD
Hydralazine—Thrombocytopenia—Methotrexate—testicular cancer	0.000729	0.00101	CcSEcCtD
Hydralazine—Arthralgia—Epirubicin—testicular cancer	0.000727	0.001	CcSEcCtD
Hydralazine—Myalgia—Epirubicin—testicular cancer	0.000727	0.001	CcSEcCtD
Hydralazine—Agitation—Doxorubicin—testicular cancer	0.000726	0.001	CcSEcCtD
Hydralazine—Anxiety—Epirubicin—testicular cancer	0.000724	0.000999	CcSEcCtD
Hydralazine—Discomfort—Epirubicin—testicular cancer	0.000718	0.000991	CcSEcCtD
Hydralazine—Malaise—Doxorubicin—testicular cancer	0.000712	0.000983	CcSEcCtD
Hydralazine—Anorexia—Methotrexate—testicular cancer	0.00071	0.000979	CcSEcCtD
Hydralazine—Leukopenia—Doxorubicin—testicular cancer	0.000707	0.000976	CcSEcCtD
Hydralazine—Palpitations—Doxorubicin—testicular cancer	0.000698	0.000963	CcSEcCtD
Hydralazine—Oedema—Epirubicin—testicular cancer	0.000697	0.000961	CcSEcCtD
Hydralazine—Hypotension—Methotrexate—testicular cancer	0.000696	0.00096	CcSEcCtD
Hydralazine—Thrombocytopenia—Epirubicin—testicular cancer	0.000682	0.000941	CcSEcCtD
Hydralazine—Tachycardia—Epirubicin—testicular cancer	0.00068	0.000938	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000678	0.000936	CcSEcCtD
Hydralazine—Myalgia—Doxorubicin—testicular cancer	0.000672	0.000928	CcSEcCtD
Hydralazine—Arthralgia—Doxorubicin—testicular cancer	0.000672	0.000928	CcSEcCtD
Hydralazine—Anxiety—Doxorubicin—testicular cancer	0.00067	0.000925	CcSEcCtD
Hydralazine—Paraesthesia—Methotrexate—testicular cancer	0.000668	0.000922	CcSEcCtD
Hydralazine—Discomfort—Doxorubicin—testicular cancer	0.000664	0.000917	CcSEcCtD
Hydralazine—Anorexia—Epirubicin—testicular cancer	0.000664	0.000916	CcSEcCtD
Hydralazine—Dyspnoea—Methotrexate—testicular cancer	0.000664	0.000916	CcSEcCtD
Hydralazine—Dyspepsia—Methotrexate—testicular cancer	0.000655	0.000904	CcSEcCtD
Hydralazine—Hypotension—Epirubicin—testicular cancer	0.000651	0.000898	CcSEcCtD
Hydralazine—Decreased appetite—Methotrexate—testicular cancer	0.000647	0.000893	CcSEcCtD
Hydralazine—Oedema—Doxorubicin—testicular cancer	0.000645	0.000889	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000643	0.000887	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000635	0.000876	CcSEcCtD
Hydralazine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000631	0.000871	CcSEcCtD
Hydralazine—Tachycardia—Doxorubicin—testicular cancer	0.000629	0.000868	CcSEcCtD
Hydralazine—Paraesthesia—Epirubicin—testicular cancer	0.000626	0.000863	CcSEcCtD
Hydralazine—Dyspnoea—Epirubicin—testicular cancer	0.000621	0.000857	CcSEcCtD
Hydralazine—Anorexia—Doxorubicin—testicular cancer	0.000614	0.000848	CcSEcCtD
Hydralazine—Feeling abnormal—Methotrexate—testicular cancer	0.000613	0.000846	CcSEcCtD
Hydralazine—Dyspepsia—Epirubicin—testicular cancer	0.000613	0.000846	CcSEcCtD
Hydralazine—Decreased appetite—Epirubicin—testicular cancer	0.000606	0.000836	CcSEcCtD
Hydralazine—Hypotension—Doxorubicin—testicular cancer	0.000602	0.000831	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000601	0.00083	CcSEcCtD
Hydralazine—Constipation—Epirubicin—testicular cancer	0.000596	0.000822	CcSEcCtD
Hydralazine—Urticaria—Methotrexate—testicular cancer	0.000591	0.000816	CcSEcCtD
Hydralazine—Body temperature increased—Methotrexate—testicular cancer	0.000588	0.000812	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000587	0.00081	CcSEcCtD
Hydralazine—Paraesthesia—Doxorubicin—testicular cancer	0.000579	0.000799	CcSEcCtD
Hydralazine—Dyspnoea—Doxorubicin—testicular cancer	0.000575	0.000793	CcSEcCtD
Hydralazine—Feeling abnormal—Epirubicin—testicular cancer	0.000574	0.000792	CcSEcCtD
Hydralazine—Dyspepsia—Doxorubicin—testicular cancer	0.000567	0.000783	CcSEcCtD
Hydralazine—Decreased appetite—Doxorubicin—testicular cancer	0.00056	0.000773	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000556	0.000768	CcSEcCtD
Hydralazine—Urticaria—Epirubicin—testicular cancer	0.000553	0.000764	CcSEcCtD
Hydralazine—Constipation—Doxorubicin—testicular cancer	0.000551	0.000761	CcSEcCtD
Hydralazine—Body temperature increased—Epirubicin—testicular cancer	0.000551	0.00076	CcSEcCtD
Hydralazine—Hypersensitivity—Methotrexate—testicular cancer	0.000548	0.000757	CcSEcCtD
Hydralazine—Feeling abnormal—Doxorubicin—testicular cancer	0.000531	0.000733	CcSEcCtD
Hydralazine—Pruritus—Methotrexate—testicular cancer	0.000527	0.000727	CcSEcCtD
Hydralazine—Hypersensitivity—Epirubicin—testicular cancer	0.000513	0.000708	CcSEcCtD
Hydralazine—Urticaria—Doxorubicin—testicular cancer	0.000512	0.000707	CcSEcCtD
Hydralazine—Body temperature increased—Doxorubicin—testicular cancer	0.00051	0.000703	CcSEcCtD
Hydralazine—Diarrhoea—Methotrexate—testicular cancer	0.000509	0.000703	CcSEcCtD
Hydralazine—Pruritus—Epirubicin—testicular cancer	0.000493	0.00068	CcSEcCtD
Hydralazine—Dizziness—Methotrexate—testicular cancer	0.000492	0.000679	CcSEcCtD
Hydralazine—Diarrhoea—Epirubicin—testicular cancer	0.000477	0.000658	CcSEcCtD
Hydralazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000475	0.000655	CcSEcCtD
Hydralazine—Vomiting—Methotrexate—testicular cancer	0.000473	0.000653	CcSEcCtD
Hydralazine—Rash—Methotrexate—testicular cancer	0.000469	0.000648	CcSEcCtD
Hydralazine—Dermatitis—Methotrexate—testicular cancer	0.000469	0.000647	CcSEcCtD
Hydralazine—Headache—Methotrexate—testicular cancer	0.000466	0.000644	CcSEcCtD
Hydralazine—Dizziness—Epirubicin—testicular cancer	0.000461	0.000636	CcSEcCtD
Hydralazine—Pruritus—Doxorubicin—testicular cancer	0.000456	0.000629	CcSEcCtD
Hydralazine—Vomiting—Epirubicin—testicular cancer	0.000443	0.000611	CcSEcCtD
Hydralazine—Nausea—Methotrexate—testicular cancer	0.000442	0.00061	CcSEcCtD
Hydralazine—Diarrhoea—Doxorubicin—testicular cancer	0.000441	0.000609	CcSEcCtD
Hydralazine—Rash—Epirubicin—testicular cancer	0.000439	0.000606	CcSEcCtD
Hydralazine—Dermatitis—Epirubicin—testicular cancer	0.000439	0.000606	CcSEcCtD
Hydralazine—Headache—Epirubicin—testicular cancer	0.000436	0.000602	CcSEcCtD
Hydralazine—Dizziness—Doxorubicin—testicular cancer	0.000426	0.000588	CcSEcCtD
Hydralazine—Nausea—Epirubicin—testicular cancer	0.000414	0.000571	CcSEcCtD
Hydralazine—Vomiting—Doxorubicin—testicular cancer	0.00041	0.000566	CcSEcCtD
Hydralazine—Rash—Doxorubicin—testicular cancer	0.000406	0.000561	CcSEcCtD
Hydralazine—Dermatitis—Doxorubicin—testicular cancer	0.000406	0.00056	CcSEcCtD
Hydralazine—Headache—Doxorubicin—testicular cancer	0.000404	0.000557	CcSEcCtD
Hydralazine—Nausea—Doxorubicin—testicular cancer	0.000383	0.000528	CcSEcCtD
